GlycoMimetics, Inc. (GLYC) Social Stream



GlycoMimetics, Inc. (GLYC): $0.32

0.03 (+11.77%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add GLYC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#234 of 358

in industry

GLYCOMIMETICS INC (GLYC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering GLYC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 4 $15 $3.001 $10.667 $2.8 280.96%
2022-04-28 4 $15 $4 $11 $2.8 292.86%
2022-11-09 2 $13 $3 $8 $2.8 185.71%
2022-12-13 3 $13 $3 $8 $2.8 185.71%
2023-02-10 3 $13 $5 $9 $2.8 221.43%
2023-11-06 3 $8 $3 $5.5 $2.8 96.43%
2023-12-22 4 $12 $3 $7.666 $2.8 173.79%

The Trend in the Analyst Price Target


Over the past 26 months, GLYC's average price target has gone down $3.33.

GLYC reports an average of 255.84% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-10 3 13 5 9.0 3.480 158.62%
2023-02-16 3 8 3 5.5 1.815 203.03%
2023-03-30 3 8 3 5.5 1.250 340%
2023-05-04 3 8 3 5.5 1.460 276.71%
2023-11-06 4 8 3 5.5 1.330 313.53%

GLYC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


GLYC's average broker recommendation rating improved by 0 over the prior 13 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, GLYCOMIMETICS INC's average analyst price target is greater than 87.19% of them.
  • GLYCOMIMETICS INC's number of analysts covering the stock is greater than 99.15% of all US stocks.
  • In the context of all US stocks, GLYCOMIMETICS INC's variance in analysts' estimates is lower than -799.57% of them.
  • GLYC has a greater upside potential (average analyst target price relative to current price) than 671.33% of stocks in the small market cap category.

Stocks similar to GLYCOMIMETICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TRVN, MRNS, and CRBP.

What is the outlook for GLYC? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!